Multiparameter flow cytometry in the evaluation of myelodysplasia: analytical issues: recommendations from the European Leukemianet/International Myelodysplastic …
A Porwit, MC Béné, C Duetz, S Matarraz… - Cytometry Part B …, 2023 - Wiley Online Library
Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European …
AA Van De Loosdrecht, R Ireland, W Kern… - Leukemia & …, 2013 - Taylor & Francis
An international working group within the European LeukemiaNet gathered, aiming to
determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was …
determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was …
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
TM Westers, R Ireland, W Kern, C Alhan, JS Balleisen… - Leukemia, 2012 - nature.com
Flow cytometry (FC) is increasingly recognized as an important tool in the diagnosis and
prognosis of myelodysplastic syndromes (MDS). However, validation of current assays and …
prognosis of myelodysplastic syndromes (MDS). However, validation of current assays and …
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European …
A Porwit, AA Van De Loosdrecht, P Bettelheim… - Leukemia, 2014 - nature.com
Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by
flow cytometry (FCM) since the publication of the World Health Organization 2008 …
flow cytometry (FCM) since the publication of the World Health Organization 2008 …
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre …
Background Data to inform surveillance and treatment for leukaemia predisposition
syndromes are scarce and recommendations are largely based on expert opinion. This …
syndromes are scarce and recommendations are largely based on expert opinion. This …
[HTML][HTML] Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
TM Westers, EMP Cremers, U Oelschlaegel… - …, 2017 - ncbi.nlm.nih.gov
Current recommendations for diagnosing myelodysplastic syndromes endorse flow
cytometry as an informative tool. Most flow cytometry protocols focus on the analysis of …
cytometry as an informative tool. Most flow cytometry protocols focus on the analysis of …
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
LE Brodersen, RB Gerbing, ML Pardo… - Blood …, 2020 - ashpublications.org
Risk stratification for acute myeloid leukemia (AML) uses molecular and cytogenetic
abnormalities identified at diagnosis. Response to therapy informs risk, and morphology …
abnormalities identified at diagnosis. Response to therapy informs risk, and morphology …
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
U Oelschlaegel, L Oelschlaeger… - Cytometry Part B …, 2023 - Wiley Online Library
Background Flow cytometry (FCM) is a co‐criterion in myelodysplastic syndromes (MDS)
diagnostics according to the WHO classification. The presented study compared diagnostic …
diagnostics according to the WHO classification. The presented study compared diagnostic …
Nobiletin promotes megakaryocytic differentiation through the MAPK/ERK-dependent EGR1 expression and exerts anti-leukemic effects in human chronic myeloid …
Differentiation therapy is an alternative strategy used to induce the differentiation of blast
cells toward mature cells and to inhibit tumor cell proliferation for cancer treatment. Nobiletin …
cells toward mature cells and to inhibit tumor cell proliferation for cancer treatment. Nobiletin …
The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system
C Alhan, TM Westers, EMP Cremers, C Cali, BI Witte… - Leukemia, 2016 - nature.com
The prognosis of myelodysplastic syndromes (MDS) is currently estimated by using the
revised International Prognostic Scoring System (IPSS-R). Several studies have shown that …
revised International Prognostic Scoring System (IPSS-R). Several studies have shown that …